Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 28;10(7):1207.
doi: 10.3390/healthcare10071207.

A Systematic Review of Clinical Outcomes from Pharmacist Provided Medication Therapy Management (MTM) among Patients with Diabetes, Hypertension, or Dyslipidemia

Srujitha Marupuru  1 , Alexis Roether  1 , A J Guimond  1 , Chris Stanley  1 , Tyler Pesqueira  1 , David R Axon  1
Affiliations
Review

A Systematic Review of Clinical Outcomes from Pharmacist Provided Medication Therapy Management (MTM) among Patients with Diabetes, Hypertension, or Dyslipidemia

Srujitha Marupuru et al. Healthcare (Basel). .

Abstract

This study aimed to compare the clinical outcomes of pharmacist-provided medication therapy management (MTM) services as compared to no MTM services (i.e., standard of care) on outpatient clinical outcomes for patients with diabetes, hypertension, or dyslipidemia. A systematic literature review of PubMed, EMBASE, Cochrane library, International Pharmaceutical Abstracts, PsycINFO, Scopus, CINAHL electronic databases, grey literature, websites, and journals, was conducted from 1 January 2005-20 July 2021. The search field contained a combination of keywords and MeSH terms such as: "medication therapy management", "pharmacist", "treatment outcomes". Studies published in United States, included adults ≥18 years old who received at least one pharmacist-provided MTM consultation and at least one group who received no MTM, and reported pre-specified clinical outcomes for diabetes mellitus, hypertension, or dyslipidemia were included. Of 849 studies identified, eight were included (cohort studies = 6, randomized controlled trials = 2). Clinical outcomes improved with MTM interventions, as evidenced by statistically significant changes in at least one of the three chronic conditions in most studies. Improvements were observed for diabetes outcomes (n = 4 studies), hypertension outcomes (n = 4 studies), and dyslipidemia outcomes (n = 3 studies). Overall, this study indicated that pharmacist delivered MTM services (versus no MTM services) can improve clinical outcomes for patients with diabetes, hypertension, and dyslipidemia.

Keywords: Medication therapy management; clinical outcomes; pharmacist.

PubMed Disclaimer

Conflict of interest statement

Dr. Marupuru reports grant funding from Tabula Rasa HealthCare Group outside of this study. Dr. Axon reports grant funding from the American Association of Colleges of Pharmacy, Arizona Department of Health, Merck and Co., Pharmacy Quality Alliance, and Tabula Rasa HealthCare Group, outside of this study. All other authors declare no relevant conflict of interest or financial relationships.

Figures

Figure 1
Figure 1
Medline/PubMed search strategy.
Figure 2
Figure 2
PRISMA flowchart.
See this image and copyright information in PMC

References

    1. Joint Commission of Pharmacy Practitioners The Pharmacists’ Patient Care Process. [(accessed on 24 January 2022)]. Available online: https://jcpp.net/wp-content/uploads/2016/03/PatientCareProcess-with-supp....
    1. H.R.1—108th Congress (2003–2004): Medicare Prescription Drug, Improvement, and Modernization Act of 2003. [(accessed on 24 January 2022)]; Available online: https://www.congress.gov/bill/108th-congress/house-bill/1.
    1. Bluml B.M. Definition of Medication Therapy Management: Development of Professionwide Consensus. J. Am. Pharm. Assoc. 2005;45:566–572. doi: 10.1331/1544345055001274. - DOI - PubMed
    1. Chavez-Valdez A.L. Release of the CY 2020 MTM Program Submission Module in HPMS a CMS-Approved MTM Program Is One of Several Required Elements in the Development of a Medicare Part D Sponsor’s Bid. Annually, Sponsors Must Submit an MTM Program. [(accessed on 24 January 2022)];2019 Available online: https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrug....
    1. The Centers for Medicare & Medicaid Services 2016 Final Advance Notice. [(accessed on 24 January 2022)]; Available online: https://www.cms.gov/Medicare/HealthPlans/MedicareAdvtgSpecRateStats/Down....

LinkOut - more resources